The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer’s disease (AD) and Age-Related Macular Degeneration (AMD)
Open accessAbstract
Alzheimer's disease (AD) of the brain neocortex and age-related macular degeneration (AMD) of the retina are two complex neurodegenerative disorders, which (i) involve the progressive dysregulation and deterioration of multiple neurobiological signaling pathways, (ii) exhibit the temporal accumulation of pro-inflammatory lesions including the amyloid beta (Aβ) peptide-containing senile plaques of AD and the drusen of AMD, and (iii) culminate in an insidious inflammatory neurodegeneration ending, respectively, in neural cell atrophy and death and progressive loss of cognition and central visual function. Recent independent research studies have indicated that AD and AMD share common, pathological signaling defects and disease mechanisms at the molecular genetic level. Using high-integrity total RNA samples pooled from AD brain and AMD retina, microfluidic hybridization miRNA arrays, and bioinformatics, the current study was undertaken to quantify microRNA (miRNA) speciation and complexity common to both AD and AMD. These small non-coding (sncRNAs) are known to post-transcriptionally regulate multiple neurobiological pathways and an abundance of research information has already been generated on the roles of these miRNAs in pathological situations involving inflammatory neuropathology and neural cell decline. Here, for the first time, we report the sequence and abundance of a septet of sncRNAs including miRNA-7, miRNA-9-1, miRNA-23a/miRNA-27a, miRNA-34a, miRNA-125b-1, miRNA-146a, and miRNA-155 that are significantly increased in abundance and common to both AD-affected superior temporal lobe neocortex (Brodmann A22) and the AMD-affected macular region of the retina. Bioinformatics, miRNA-mRNA complementarity, next-gen RNA sequencing, and feature alignment analysis further indicate that these 7 up-regulated miRNAs have the potential to interact with and down-regulate ~ 9460 target messenger RNAs (mRNAs; about 3.5% of the genome) involved in the synchronization of amyloid production and clearance, phagocytosis, innate-immune, pro-inflammatory, and neurotrophic signaling and/or synaptogenesis in diseased tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and elevated miRNA-7 levels can downregulate the expression of genes involved in Aβ clearance [622]”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [622]
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
miRBase: annotating high confidence microRNAs using deep sequencing data
Kozomara, A., & Griffiths-Jones, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1181 · Cited by 5,073
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
Ambros, V. (2001) · Cell · doi:10.1016/s0092-8674(01)00616-x · Cited by 1,705
2017 Alzheimer's disease facts and figures
(, T. D. B. T. A.-R. C. C. A. S. O. A. C. B. S., different, ). J. A. I. A., destroyed, S. A. T. A. S. T. M. E. T. M. C. I. S. I. A. G. W. A. T. R. N. I. T. O. B. T. F. N. T. B. D. A. D. A. U. I. B. R. I. I. F. N. M. A. N. I. O. P. O. T. B. A. D. A., difficulties, I. E. O., agitation, I. N. S. S. A., & delusions., S. A. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.02.001 · Cited by 1,366
An unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration
Lehmann, S. M., Krüger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3113 · Cited by 786
Rappaport, N., Twik, M., Plaschkes, I., Nudel, R., Stein, T. I., Levitt, J., Gershoni, M., Morrey, C. P., Safran, M., & Lancet, D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1012 · Cited by 684
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus
Lukiw, W. J. (2007) · NeuroReport · doi:10.1097/wnr.0b013e3280148e8b · Cited by 530
Self-citationColangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517
Self-citationLukiw, W. J., Zhao, Y., & Cui, J. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805371200 · Cited by 441
Self-citation
Research works printed but not linked: 1
- Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN (2012a) Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in AD and in AMD. Int J Biochem Mol Biol 3:105–116
Cited by
Sorted by citations
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Czubowicz, K., Jęśko, H. M., Wencel, P. L., Lukiw, W. J., & Strosznajder, R. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1448-3 · Cited by 303
Self-citationEpigenetics of Alzheimer’s Disease
Perković, M. N., Paska, A. V., Konjevod, M., Kouter, K., Štrac, D. Š., Erjavec, G. N., & Pivac, N. (2021) · Biomolecules · doi:10.3390/biom11020195 · Cited by 192
The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications
Liu, X., Jiao, B., & Shen, L. H. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00579 · Cited by 153
Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration
Zhao, Y., & Lukiw, W. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1015-y · Cited by 134
Self-citationHuang, Y., Cheng, L., Turchinovich, A. A., Mahairaki, V., Troncoso, J. C., Pletniková, O., Haughey, N. J., Vella, L. J., Hill, A. F., Zheng, L., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1785746 · Cited by 118
Jun, S., Datta, S., Wang, L., Pegany, R. B., Cano, M., & Handa, J. T. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.09.023 · Cited by 114
microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
Zhao, Y., Jaber, V. R., Alexandrov, P. N., Vergallo, A., Lista, S., Hampel, H. J., & Lukiw, W. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.585432 · Cited by 99
Self-citationA Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer’s Disease
Herrera-Espejo, S., Santos-Zorrozua, B., Álvarez-González, P., Lopez-Lopez, E., & Garcia-Orad, Á. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01676-9 · Cited by 81
Viral Involvement in Alzheimer’s Disease
Sait, A. M., Angeli, C., Doig, A. J., & Day, P. J. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00719 · Cited by 90
Colligris, P., de Lara, M. J. P., Colligris, B., & Pintor, J. J. (2018) · Journal of Ophthalmology · doi:10.1155/2018/8538573 · Cited by 84
Wang, L., & Mao, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052360 · Cited by 86
Epigenetics in Alzheimer’s Disease
Gao, X., Chen, Q., Yao, H., Tan, J., Liu, Z., Zhou, Y., & Zou, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.911635 · Cited by 89
Crosstalk between MicroRNA and Oxidative Stress in Primary Open-Angle Glaucoma
Tabak, S., Schreiber‐Avissar, S., & Beit‐Yannai, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052421 · Cited by 73
Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer’s Disease
Wolinsky, D., Drake, K., & Bostwick, J. R. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0978-8 · Cited by 73
Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier
Beygi, M. H. M., Oroojalian, F., Azizi‐Arani, S., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202310881 · Cited by 66
Cieślik, M., Czapski, G. A., Wójtowicz, S., Wieczorek, I., Wencel, P. L., Strosznajder, R. P., Jaber, V. R., Lukiw, W. J., & Strosznajder, J. B. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01819-y · Cited by 61
Self-citationJabbehdari, S., & Handa, J. T. (2020) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.09.002 · Cited by 61
Inflamma-MicroRNAs in Alzheimer’s Disease: From Disease Pathogenesis to Therapeutic Potentials
Liang, Y., & Wang, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.785433 · Cited by 56
Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder
Lee, S.-Y., Lu, R., Wang, L., Chang, C., Lu, T., Wang, T., & Tsai, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-58195-0 · Cited by 56
Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer’s disease
Chen, J.-J., Yang, G., Yan, Q., Zhao, J., & Li, S. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0001 · Cited by 48
Litwińska, Z., Sobuś, A., Łuczkowska, K., Grabowicz, A., Mozolewska‐Piotrowska, K., Safranow, K., Kawa, M. P., Machaliński, B., & Machalińska, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00286 · Cited by 49
Vesicular Transport of Encapsulated microRNA between Glial and Neuronal Cells
Lukiw, W. J., & Pogue, A. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145078 · Cited by 48
Self-citationMicrobiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease
Zhao, Y., & Lukiw, W. J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00145 · Cited by 47
Self-citationTREM2 expression and amyloid‐beta phagocytosis in Alzheimer's disease
La Rosa, F., Agostini, S., Piancone, F., Marventano, I., Hernis, A., Fenoglio, C., Galimberti, D., Scarpini, E., Saresella, M., & Clerici, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108626 · Cited by 50
Hu, Z., Lv, X., Chen, L., Gu, X., Qian, H., Fransisca, S., Zhang, Z., Liu, Q., & Xie, P. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28523 · Cited by 47
Zhao, Y., Jaber, V. R., LeBeauf, A., Sharfman, N. M., & Lukiw, W. J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00028 · Cited by 44
Self-citationThe pro‐inflammatory microRNA miR‐155 influences fibrillar β‐Amyloid1‐42 catabolism by microglia
Aloi, M. S., Prater, K. E., Sopher, B., Davidson, S., Jayadev, S., & Garden, G. A. (2021) · Glia · doi:10.1002/glia.23988 · Cited by 43
The Role of Deregulated MicroRNAs in Age-Related Macular Degeneration Pathology
Elshelmani, H., Wride, M. A., Saad, T., Rani, S., Kelly, D. J. A., & Keegan, D. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.2.12 · Cited by 42
miR-146a Dysregulates Energy Metabolism During Neuroinflammation
Kim, S. J., Russell, A. E., Wang, W., Gemoets, D. E., Sarkar, S. N., Simpkins, J. W., & Brown, C. M. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-09999-y · Cited by 41
Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease
Singh, A., & Verma, S. (2020) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_999_19 · Cited by 36
Epigenetic basis of Alzheimer disease
Tecalco-Cruz, Á. C., Ramírez‐Jarquín, J. O., Álvarez-Sánchez, M. E., & Zepeda–Cervantes, J. (2020) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v11.i2.62 · Cited by 37
MiR-29c-3p May Promote the Progression of Alzheimer’s Disease through BACE1
Cao, Y., Tan, X., Lu, Q., Huang, K., Tang, X.-E., & He, Z. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/2031407 · Cited by 36
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Jeremic, D., Jiménez‐Díaz, L., & Navarro‐López, J. D. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102003 · Cited by 36
Epigenetics in Age-related Macular Degeneration (AMD)
Desmettre, T. J. (2018) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2018.09.001 · Cited by 35
The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases
Nuzziello, N., & Liguori, M. (2019) · Cells · doi:10.3390/cells8101193 · Cited by 36
MiRNAs as major players in brain health and disease: current knowledge and future perspectives
Kapplingattu, S. V., Bhattacharya, S., & Adlakha, Y. K. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02283-x · Cited by 44
Tsai, H., Lo, R. Y., Liang, K., Chen, T., Huang, H., Wang, J., & Lee, Y. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.11.005 · Cited by 32
microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD)
Pogue, A. I., & Lukiw, W. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179198 · Cited by 30
Self-citationMartinez, B., & Peplow, P. V. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.293131 · Cited by 27
Lukiw, W. J., Li, W., Bond, T., & Zhao, Y. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00545 · Cited by 27
Self-citationThe miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer's disease
Yashooa, R. K., & Nabi, A. Q. (2022) · Human Gene · doi:10.1016/j.humgen.2022.201129 · Cited by 27
Alzheimer’s Disease: the Potential of Epigenetic Treatments and Current Clinical Candidates
Coneys, R., & Wood, I. C. (2020) · Neurodegenerative Disease Management · doi:10.2217/nmt-2019-0034 · Cited by 26
Varma-Doyle, A. V., Lukiw, W. J., Zhao, Y., Lovera, J. F., & Devier, D. J. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117202 · Cited by 26
Self-citationRecent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review
Finocchio, L., Zeppieri, M., Gabai, A., Toneatto, G., Spadea, L., & Salati, C. (2023) · Biomedicines · doi:10.3390/biomedicines11123221 · Cited by 31
Aschner, M., Skalny, A. V., Santamarı́a, A., da Rocha, J. B. T., Mansouri, B., Tizabi, Y., Madeddu, R., Lu, R., Lee, E.-S., & Tinkov, A. A. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04214-9 · Cited by 25
The Role of MicroRNAs in Mitochondria-Mediated Eye Diseases
Carrella, S., Massa, F., & Indrieri, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653522 · Cited by 24
miR-203, fine-tunning neuroinflammation by juggling different components of NF‐κB signaling
Li, S., Li, L., Li, J., Liang, X., Song, C., & Zou, Y. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02451-9 · Cited by 22
Tan, Z., Li, W., Cheng, X., Zhu, Q., & Zhang, X. (2022) · Biomolecules · doi:10.3390/biom13010018 · Cited by 25
Gao, N., Zhang, Y., Gao, K., Xie, J., Liu, L., Li, Y., Qiu, L., Wei, Q. L., Ma, H., & Pang, X. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.127576 · Cited by 23
A Comprehensive Review on the Role of Non-Coding RNAs in the Pathophysiology of Bipolar Disorder
Ghafouri‐Fard, S., Badrlou, E., Taheri, M. N., Dürsteler, K. M., Brühl, A. B., Bahmani, D. S., & Brand, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105156 · Cited by 23
Zhang, Q., Kaixin, Z., Yanfei, H., Zhang, Y., Hua, X., Ling, Z., Guangliang, S., & Li, S. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30178 · Cited by 21
O’Meara, T. A., Kong, Y., Chiarella, J., Price, R. W., Chaudhury, R., Liu, X., Spudich, S., Robertson, K., Emu, B., & Lu, L. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002187 · Cited by 20
Peplow, P., & Martinez, B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.295271 · Cited by 19
Urbańska, K., Stępień, P. W., Nowakowska, K. N., Stefaniak, M., Osial, N., Chorągiewicz, T., Toro, M. D., Nowomiejska, K., & Ręjdak, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147761 · Cited by 19
MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s disease
Wijesinghe, P., Xi, J., Cui, J. Z., Campbell, M., Pham, W. N., & Matsubara, J. A. (2023) · Life Science Alliance · doi:10.26508/lsa.202201757 · Cited by 20
Retinal Neuroprotection: Overcoming the Translational Roadblocks
Wubben, T. J., Besirli, C. G., Johnson, M. W., & Zacks, D. N. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.04.012 · Cited by 19
Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
Elshelmani, H., Brennan, I., Kelly, D. J. A., & Keegan, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212321 · Cited by 19
Salama, R. M., Eissa, N., Doghish, A. S., Abulsoud, A. I., Abdelmaksoud, N. M., Mohammed, O. A., Mageed, S. S. A., & Darwish, S. F. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1373741 · Cited by 18
An update: mechanisms of microRNA in primary open-angle glaucoma
Wang, Y., Niu, L., Zhao, J., Wang, M., Li, K., & Zheng, Y. (2020) · Briefings in Functional Genomics · doi:10.1093/bfgp/elaa020 · Cited by 19
Mohammed, O. A., Elballal, M. S., El-Husseiny, A. A., Khidr, E. G., Tabaa, M. M. E., Elazazy, O. E., Abd‐Elmawla, M. A., Elesawy, A. E., Ibrahim, H. M., Abulsoud, A. I., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155023 · Cited by 16
Microfluidic epigenomic mapping technologies for precision medicine
Deng, C., Naler, L. B., & Lu, C. (2019) · Lab on a Chip · doi:10.1039/c9lc00407f · Cited by 17
Han, S., Shin, J., Jung, H., Ryu, J., Minassie, H., Nho, K., Koh, I., & Lee, Y. (2021) · npj Systems Biology and Applications · doi:10.1038/s41540-021-00177-7 · Cited by 16
AMD Genomics: Non-Coding RNAs as Biomarkers and Therapeutic Targets
Zhang, C., Owen, L. A., Lillvis, J. H., Zhang, S. X., Kim, I. K., & DeAngelis, M. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061484 · Cited by 19
The impact of substrate stiffness on morphological, transcriptional and functional aspects in RPE
Wolfram, L., Gimpel, C., Schwämmle, M. E., Clark, S. J., Böhringer, D., & Schlunck, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-56661-7 · Cited by 15
Zhao, J., Xu, J., Zhang, Z., Shao, Z., & Meng, D. (2022) · Phytochemistry · doi:10.1016/j.phytochem.2022.113430 · Cited by 14
Lin, Y., Yoo, J. M., Li, D., Heo, Y., Okumura, M., Won, H., Vendruscolo, M., Lim, M. H., & Lee, Y. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00507-3 · Cited by 16
Genetic and Epigenetic Biomarkers Linking Alzheimer’s Disease and Age-Related Macular Degeneration
Kaštelan, S., Nikuševa-Martić, T., Pašalić, D., Antunica, A. G., & Zimak, D. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137271 · Cited by 15
Szelągowski, A., & Kozakiewicz, M. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/7759053 · Cited by 14
Wang, H. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2023.19 · Cited by 14
MicroRNAs as potential biomarkers and therapeutic targets in age-related macular degeneration
Cruz‐Aguilar, M., Groman-Lupa, S., & Martínez, M. D. C. J. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1023782 · Cited by 13
Yin, C., Tang, X., Zeng, J., Wang, Z., Mi, J., Liang, Y. J., Qin, D., Feng, Q., & Wu, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102954 · Cited by 13
Wang, K., He, L., Liu, X., & Wu, M. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.142651 · Cited by 11
Roles of biomaterials in modulating the innate immune response in ocular therapy
Rafiei, M., Chung, J. T., & Chau, Y. (2023) · Frontiers in Drug Delivery · doi:10.3389/fddev.2023.1077253 · Cited by 10
Cong, L., Zhao, Y., Pogue, A. I., & Lukiw, W. J. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090031 · Cited by 10
Self-citationSelective microRNA expression of exosomes from retinal pigment epithelial cells by oxidative stress
Zhang, Z., Gu, Q., Chen, L., Yuan, D., Gu, X., Qian, H., Xie, P., Liu, Q., & Hu, Z. (2024) · Vision Research · doi:10.1016/j.visres.2024.108388 · Cited by 10
Therapeutic potential and microRNA regulating properties of phytochemicals in Alzheimer’s disease
Kumari, A., Rahaman, A., Zeng, X., & Baloch, Z. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102439 · Cited by 9
Chen, K.-Y., Chan, H.-C., & Chan, C.-M. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07593-x · Cited by 10
Zhao, Y., Jaber, V. R., & Lukiw, W. J. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.983030 · Cited by 9
Self-citationAmirloo, B., Staroseletz, Y., Yousaf, S., Clarke, D. J., Brown, T. P., Aojula, H. S., Аркадьевна, З. М., & Bichenkova, E. V. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1273 · Cited by 9
Mrowicka, M., Mrowicki, J., Kucharska, E., Śmigielska, B., Szaflik, J. P., Szaflik, J., & Majsterek, I. (2021) · Processes · doi:10.3390/pr9081328 · Cited by 8
Small Extracellular Vesicle-Associated MiRNAs in Polarized Retinal Pigmented Epithelium
Hernandez, B. J., Strain, M., Suarez, M. F., Stamer, W. D., Ashley‐Koch, A. E., Liu, Y., Klingeborn, M., & Rickman, C. B. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.13.57 · Cited by 9
Fission Impossible: Stabilized miRNA-Based Analogs in Neurodegenerative Disease
Lukiw, W. J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.875957 · Cited by 7
Self-citationWijesinghe, P., Li, H. R., Ai, Z., Campbell, M., Chen, S. X., Xi, J., Pham, W. N., & Matsubara, J. A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1495615 · Cited by 6
microRNA-146a as a biomarker for transmissible spongiform encephalopathy
Pogue, A. I., Zhao, Y., & Lukiw, W. J. (2022) · Folia Neuropathologica · doi:10.5114/fn.2022.113561 · Cited by 6
Self-citationÉpigénétique et myopie : mécanismes et perspectives thérapeutiques
Desmettre, T., Gatinel, D., & Leveziel, N. (2022) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2022.06.002 · Cited by 7
Highly Expressed Amyloid Beta-42 Of Aqueous Humor In Patients With Neovascular Macular Degeneration
Zhu, J., Su, T., Wang, M., Li, M., Liu, L., & Wang, F. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1883679 · Cited by 5
Peng, M., Zeng, Q., Zheng, W., & Xia, X.-B. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05078-y · Cited by 4
Wang, C., Liu, J., Miao, Z., Hu, M. S., Li, Q., Zhang, X., & Gu, L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177224 · Cited by 4
Zhang, S., Zhang, C., Zhang, Y., & Feng, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-92103-8 · Cited by 3
Genetics of Age-Related Macular Degeneration
Zavala, R. A., Hicks, P. M., Lillvis, J. H., Zhang, C., Farkas, M. H., Owen, L. A., & DeAngelis, M. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_110 · Cited by 3
Ortiz, C., Tahiri, H., Yang, C., Gilbert, C., Fortin, C. F., & Hardy, P. (2024) · Antioxidants · doi:10.3390/antiox13060646 · Cited by 2
He, Z., Yang, Q., Li, X., Wang, Z., Wen, S., Dong, M., Zhang, W., Gong, Y., Zhou, Z., Liu, Q., et al. (2024) · Small Science · doi:10.1002/smsc.202300334 · Cited by 2
Épigénétique et dégénérescence maculaire liée à l’âge (DMLA)
Desmettre, T. (2018) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2018.06.004 · Cited by 2
Absence of an Association between Macular Degeneration and Young-Onset Dementia
Kuang, T.-M. T., Xirasagar, S., Lee, W.-Y., Cheng, Y., Kuo, N., & Lin, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020291 · Cited by 2
Epigenetic Therapy for Alzheimer’s Disease
Mehak, S. F., Sahu, V., Shivakumar, A. B., Gangadharan, G., & Kabekkodu, S. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_10 · Cited by 1
Noncoding genome in eye disease
Kaczynski, T. J., & Farkas, M. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816222-4.00005-8
Russell, A. E. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3947
Genetics of Age-Related Macular Degeneration
Zavala, R. A., Hicks, P. M., Lillvis, J. H., Zhang, C., Farkas, M. H., Owen, L. A., & DeAngelis, M. M. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_110-1
Li, S., Li, L., Li, J., Liang, X., Song, C., & Zou, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19588785
Metadata
- Authors
- Pogue, A. I., & Lukiw, W. J.
- Affiliations
- Louisiana State University (US)
- Corresponding author
- Lukiw, Walter J.
- ORCID
- Lukiw, Walter J.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2018-01-04
- Volume
- 38
- Issue
- 5
- Pages
- 1021-1031
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC11481951
- OpenAlex
- W2782487815
- Cited by
- 105
- References
- 72
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 13 · 2023: 10 · 2022: 17 · 2021: 18 · 2020: 14 · 2019: 14 · 2018: 10
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG18031, AG038834)
- National Eye Institute (EY006311)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, age-related macular degeneration, microRNA, neuroinflammation, miRNA-mRNA interactions, amyloid-beta, drusen, retina, miR-34a, miRNA-146a, miR-155, innate immunity, synaptogenesis, neurodegeneration
- MeSH terms
- Alzheimer Disease, Base Sequence, Humans, Inflammation, Macular Degeneration, Up-Regulation, Oligonucleotide Array Sequence Analysis, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
